Glioblastoma Treatment - Health Technology Insights

Symphony Robotics Appoints Dr. Neil A. Martin as CMO to Lead Glioblastoma Innovation

April 28, 2025

Symphony Robotics, a pioneer in advanced neurosurgical micro-robotics, announced the appointment of renowned neurosurgeon Dr. Neil A. Martin as its Chief Medical Officer (CMO). In this pivotal

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

Laminar Pharma Shares First PFS Data for LAM561 in Glioblastoma Treatment

March 5, 2025

Laminar Pharma, a leader in the development of innovative cancer therapy based on membrane lipid therapy, announced optimistic results from its ongoing clinical trial evaluating

Categories

Tag: Glioblastoma Treatment

Symphony Robotics Appoints Dr. Neil A. Martin as CMO to Lead Glioblastoma Innovation

Laminar Pharma Shares First PFS Data for LAM561 in Glioblastoma Treatment

Share With

Recent Posts

SAS Unveils Ai Models And Solutions For Health Care Industry, Payer Organizations

Cohere Health Review Assist Accelerates Clinical Reviews for Health Plans with Precision AI

NCCN Launches Education Tool for Cancer Care Providers

Solera HALO Adds Tool for Configurable Digital Health Networks

BlueGenes and Levrx Bring Genetic Insights to Pharmacy Benefits

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands